AWARD
A -- Multi-site, randomized, double-blind, multi-arm historical control, comparative trial of the safety and efficacy of hydroxychloroquine and the combination of hydroxychloroquine and famotidine for treatment of moderate to severe COVID-19 disease in hospital
- Notice Date
- 4/22/2020 7:31:37 AM
- Notice Type
- Award Notice
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- ASPR OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE Washington DC 20201 USA
- ZIP Code
- 20201
- Solicitation Number
- 75A50120C00078
- Archive Date
- 04/29/2020
- Point of Contact
- Carl Newman, Phone: 202-205-1156
- E-Mail Address
-
carl.newman@hhs.gov
(carl.newman@hhs.gov)
- Award Number
- 75A50120C00078
- Award Date
- 04/14/2020
- Awardee
- ALCHEM LABORATORIES CORP Alachua FL USA
- Award Amount
- 20747018.00
- Description
- The objective of this contract is rapidly implement a multi-site, randomized, double-blind, multi-arm historical control, comparative trial of the safety and efficacy of Hydroxychloroquine and the combination of Hydroxychloroquine and Famotidine for the treatment of moderate to severe COVID-19 disease in hospitalized adults.� The study will help evaluate the clinical efficacy of COVID-19 treatments consisting of standard of care (SOC) combined with pharmaceutical antiviral management using Hydroxychloroquine or SOC or SOL combine with Hydroxychloroquine and high-dose intravenous famotidine in hospitalized patients meeting nucleic acid diagnostic and radiologic criteria for COVID-19 disease. Additional dose-ranging or therapeutic strategies including additional therapeutic compounds, as well as clinical sample testing, to improve COVID-19 treatments are also proposed.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/c6d74bd92f004770b40b3b7568422ba8/view)
- Record
- SN05631465-F 20200424/200422230130 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |